This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Reiko Saikawa: Innovator in Pharmaceutical Research
Introduction
Reiko Saikawa is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for medical applications. Her work focuses on addressing lower urinary tract diseases, showcasing her commitment to improving patient care.
Latest Patents
Reiko Saikawa holds a patent for an iminopyridine derivative, which has a selective α-adrenergic receptor antagonistic action. This compound is useful as an agent for the prophylaxis or treatment of lower urinary tract diseases. The patent also includes a screening method for identifying compounds with α-adrenergic receptor antagonistic action. This innovative approach involves measuring the bladder smooth muscle tension of rats with bladder outlet obstruction, highlighting the practical applications of her research.
Career Highlights
Saikawa is currently associated with Takeda Pharmaceutical Company Limited, where she continues to advance her research in pharmacology. Her dedication to innovation in drug development has positioned her as a key figure in her field.
Collaborations
Throughout her career, Reiko has collaborated with notable colleagues, including Shigemitsu Imai and Yuuichi Okabe. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Reiko Saikawa's contributions to pharmaceutical research exemplify her innovative spirit and dedication to improving healthcare solutions. Her work on iminopyridine derivatives is a testament to her impact in the field, and she continues to inspire future generations of inventors.